Harry Kissi, MD
Hospitalist · Salisbury, NCNPI 1518126267
Payments from drug & device makers
Across 35 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$139
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$75
- AbbVie$72
- Electromed, Inc.$72
- Boehringer Ingelheim$63
- Janssen Scientific Affairs, LLC$36
- plus $236 from 11 others
What the payments were for
- Food & beverage$692100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 6 | $139 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $75 |
| AbbVie(2 entities) | 5 | $72 |
| Electromed, Inc. | 3 | $72 |
| Boehringer Ingelheim | 3 | $63 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Pfizer | 2 | $34 |
| Melinta Therapeutics, LLC | 1 | $34 |
| Tactile Systems Technology Inc | 1 | $29 |
| Verona Pharma, Inc. | 1 | $23 |
| Amgen | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Alkermes, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Novartis | 1 | $16 |
| Incyte Corporation | 1 | $15 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$692 in reported general payments places this provider in the 75th percentile of 879 hospitalist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 25 | $3,619 |
| Cefdinir | 26 | $378 |
| Cephalexin | 16 | $104 |
| Atorvastatin Calcium | 13 | $101 |
| Doxycycline Hyclate | 14 | $87 |
| Amlodipine Besylate | 15 | $77 |
| Furosemide | 12 | $31 |
| Prednisone | 15 | $25 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Salisbury
- Honnie SpencerSalisbury$50K
- Kevin CannonWilmington$47.5M
- Emily Ray KoDurham$182K
- Mahesh ChandrasekharWinston Salem$100K
- Dwan VarnerGreenville$59K
- Adaorah OkaforWinston Salem$53K
- Jenna BrooksCharlotte$24K
- Ria DancelChapel Hill$13K
- Javad MonzavifarCharlotte$12K
- Bikki GautamCharlotte$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.